04 June 2025 - The South African Health Products Regulatory Authority (SAHPRA) recently visited the Egyptian Drug Authority (EDA) at their Cairo Offices for an intensive training programme to capacitate the Regulator on how to achieve recognition for the World Health Organization (WHO) Global Benchmarking...
The South African Health Products Regulatory Authority (SAHPRA) would like to inform healthcare professionals about the risk of a drug-drug interaction (DDI) associated with concomitant use of warfarin and tramadol. Taking these two medicines simultaneously can lead to an increase in the International Normalised Ratio...
Pretoria, 22 May 2025 –The South African Health Products Regulatory Authority (SAHPRA), having applied Reliance on the World Health Organization (WHO) PQ assessment under Emergency Use Listing, has listed the first mpox (monkeypox) in vitro diagnostic (IVD). This serves as an important step in improving global access to mpox testing by using a reliance process. The emergency use approval of the Alinity m MPX...
Pretoria, 04 April 2025 –The South African Health Products Regulatory Authority (SAHPRA) has joined the Medical Device Single Audit Programme (MDSAP), an international audit programme of medicines and medical device regulators aimed at improving efficiencies in the regulation of medical device manufacturers by engaging in work...
Pretoria, 24 March 2025 –The South African Health Products Regulatory Authority (SAHPRA), in partnership with Pharmacometrics Africa and the Department of Pharmacy and Pharmacology at the University of the Witwatersrand, proudly announces the graduation of the fourth cohort from the Clinical Assessors Short Course —...
The South African Health Products Regulatory Authority (SAHPRA) has published four (4) Expression of Interests (EOIs) since 2023, and these have all been closed. Updates on EOIs: Ref: SAHPRA20862023 - The EOI was closed on Friday, 15 December 2023. VET - Two (2) external evaluators for the...
Cairo, Egypt, 4 February 2025: The Africa Centres for Disease Control and Prevention (Africa CDC) and African Union Development Agency – New Partnership for Africa’s Development (AUDA-NEPAD) are proud to announce the signing of a Memorandum of Understanding (MoU) among Africa’s WHO Maturity Level 3...
Pretoria - The leading agencies, the South African Health Products Regulatory Authority (SAHPRA) and the National Department of Health (NDoH) with identified key stakeholders for the National Action Plan (NAP) are in a three-day workshop this week (4-6 February 2025) to pilot the World Health...
Pretoria, 17 January 2025 – The South African Health Products Regulatory Authority (SAHPRA) has recommended that the product information of medroxyprogesterone acetate (MPA)-containing products be amended by updating the safety warnings to include the potential risk of meningioma. MPA is a synthetic oral and injectable form...
The South African Health Products Regulatory Authority (SAHPRA) wishes to inform stakeholders that the organisation's telephone system has been restored. SAHPRA apologises for any inconvenience this may have caused. ...
